Skip to content
Home/Companies/MedTech/MTM Laboratories

MTM Laboratories

MedTech·Germany·Exited 2011·Held 8yr
Entry
2003
Hold
8yr
Exit
2011

Who owns MTM Laboratories?

MTM Laboratories was owned by Wellington Partners through Wellington Partners Life Sciences (1998 vintage) from 2003 to 2011, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-10

Wellington Partners
Investor
Wellington Partners
Wellington Partners Life Sciences · 1998 · VC

Key facts

HQGermany
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2011

More from Wellington Partners Life Sciences

Other portfolio companies in the same fund.

Beren Therapeutics
Active
BiotechUnited States· 2026
Nuclidium
Active
BiotechSwitzerland· 2026
CorFlow Therapeutics
CorFlow Therapeutics
Active
MedTechSwitzerland· 2024
SciRhom
Active
BiotechGermany· 2024
Nyra Health
Active
HealthTechAustria· 2023
Seamless Therapeutics
Seamless Therapeutics
Active
BiotechGermany· 2023

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Optos
Exited 2015
Amadeus Capital PartnersUK
to
Axomove
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Clee Medical
Clee Medical
Active
High-Tech Gruenderfonds (HTGF)Switzerland· 2026
CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Track MTM Laboratories

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on MTM Laboratories.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue